Track topics on Twitter Track topics that are important to you
KELOWNA, BRITISH COLUMBIA -- (Marketwired) -- 07/27/15 -- Green Hygienics Holdings, Inc. (OTCQB: GRYN)
As reported in June 6, 2015 8K. In conjunction with the appointment of the Company's new management, Green Hygienics has entered into the construction and management of Cannabis production facilities. The model facility is a special use building of approximately 20,000 square feet, with approximately 400 lights producing 100 lbs per week using a proprietary aeroponics growing system. These facilities are modular and scalable On the construction and management the company uses a cost plus billing system to the licence holder. Most importantly the company enters into a percentage of ongoing revenue agreement with the license holder equal to its equity investment predicted to be 10 to 20%. The combination of specialty construction methods and materials and the company's proprietary aeroponics growing system the facilities are completed at approximately half the cost of traditional construction methods while producing twice the yield when compared to peat based growing techniques. These facilities provide a mold and pest free environment for the highest quality medical use marijuana.
Rick Powell CEO states "The Cannabis industry in the USA is predicted to be a $115 billion industry with in the next 10 years. We feel it is the companies that take the large scale commercial approach to cultivation and quality control that will succeed in this industry long term. Green Hygienics is perfectly positioned to be a leader in the next stage of this fast growing, highly profitable industry".
About Green Hygienics, Inc. (OTCQB: GRYN)
Green Hygienics is a large scale, turn-key commercial indoor cultivation company, providing, design, engineering, construction and management services for the commercial cannabis industry in the United States and Canada. This is the fastest growing most dynamic industry in both the USA and Canada. The company's sterile growing environment boasts the highest Quality Assurance standards with the most control, its proprietary, soilless, scalable, production system is the highest yielding, lowest running cost method available in the industry. This produces the highest quality and most consistent product while maintaining the lowest carbon footprint.
Safe Harbor Statements
Certain information contained in this news release constitutes "forward-looking statements" as such term is used in applicable United States and Canadian laws. Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as "expects" or "does not expect," "is expected," "anticipates" or "does not anticipate," "plans," "estimates," "intends" or "believes," or that certain actions, events or results "may," "could," "would," "might" or "will be taken," "occur," or "be achieved." Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made, and are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements. Many of these factors are beyond the Company's ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company's filings with the SEC. Such risks and other factors include, among others, the ability to locate and acquire suitable interests in alternative medicine manufacturing operations on terms acceptable to the Company, the availability of financing on acceptable terms, accidents, labor disputes, acts of God and other risks of the alternative medicine industry including, without limitation, delays in obtaining governmental approvals or permits, title disputes or claims limitations on insurance coverage. The Company believes that the expectations reflected in the forward-looking statements included in this news release are reasonable; however, no assurance can be given that these expectations will prove to be correct, and such forward-looking statements should not be unduly relied upon. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise.Contacts: Green Hygienics, Inc. Investor Relations 1888 700 GRYN (4796) NEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...